Emphysema News and Research

Latest Emphysema News and Research

Consumer groups, market experts support repeal of Medicare bidding program

Providers of home medical equipment and services in Oregon support H.R. 1041, a bipartisan bill in Congress that would repeal the controversial Medicare "competitive" bidding program for certain medically required equipment and services used at home.

4 Jun 2011

WHO warns of tobacco dangers on World No Tobacco Day

"Tobacco will kill nearly six million people this year, including 600,000 non-smokers, because governments are not doing enough to persuade people to quit or protect others from second-hand smoke, the World Health Organization (WHO) said on Tuesday," which was observed as World No Tobacco Day, Reuters/Toronto Sun reports.

2 Jun 2011

Pulmonx announces new clinical data of Zephyr endobronchial valve in emphysema

Pulmonx Inc. has announced new clinical data from its Chartis multi-center study, presented at the American Thoracic Society's 2011 International Conference.

25 May 2011

Lung protein appears to play a key role in smoking-related emphysema

An international research team has identified a lung protein that appears to play a key role in smoking-related emphysema and have crafted an antibody to block its activity, Indiana University scientists reported.

17 May 2011

COPD Foundation to host biannual conference in the U.S. for the first time

Originally hosted in Europe on even calendar years, the COPD Conference series for researchers and healthcare professionals is coming to the U.S. for the first time. The COPD Foundation is hosting the COPD7USA Conference, named after the seventh COPD Conference held last summer in the U.K. COPD7USA will be held on December 3rd and 4th at the Crystal City Gateway Marriott, 1700 Jefferson Davis Highway, Crystal City, VA 22202.

17 May 2011

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

Researchers have linked a variant in the vitamin D receptor gene (VDR) with the onset of chronic obstructive pulmonary disease (COPD) in Caucasian men. The study population consisted of participants in the Veterans Administration Normative Aging Study, a multidisciplinary study of aging that began in 1963.

16 May 2011

Rotech Healthcare first quarter adjusted EBITDA increases 13% to $28.3 million

Rotech Healthcare Inc. today announced financial results for the first quarter ended March 31, 2011.

7 May 2011

Workload, time constraints hold nurses to lead global fight against non-communicable diseases

Nurses want to lead in the global fight against the further spread of non-communicable diseases but workload and time constraints are holding them back, according to a major new survey by the International Council of Nurses and Pfizer.

6 May 2011

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

Transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide, according to an animal study in the April 18 online edition of the Journal of Clinical Investigation.

22 Apr 2011

Novartis NVA23 Phase III trial in COPD achieves primary end point

Sosei Group Corporation announces that NVA237, a long-acting muscarinic antagonist being investigated as a once daily treatment for chronic obstructive pulmonary disease, achieved its primary end point in a Phase III study.

19 Apr 2011

Scientist discovers new molecular mechanism underlying asthma, COPD

Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.

18 Apr 2011

Merz launches 'Make Your Mark' campaign to raise awareness on cervical dystonia

Merz Pharmaceuticals, LLC, maker of XEOMIN, a botulinum toxin type A free from accessory proteins, today announced the launch of the "Make Your Mark" campaign.

15 Apr 2011

Researchers develop non-steroid based strategy for patients with COPD

Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung's innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease.

15 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

Chronic Obstructive Pulmonary Disease (COPD) is a major cause for hospital stays and emergency room visits across Canada and researchers say minimizing exacerbations or flare-ups of the disease can go a long way to reducing hospitalizations.

25 Mar 2011

Rotech closes private offering of $290M in Senior Notes due 2018

Rotech Healthcare Inc. announced the closing of its previously announced offering of $290 million in aggregate principal amount of Senior Second Lien Notes due 2018.

19 Mar 2011

EMP levels may help clinicians diagnose early emphysema

Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles, are shed during the disease process as tiny blood vessels in the lungs, called pulmonary capillaries, are injured and die.

14 Mar 2011

Test that measures destruction of lung air sacs, could help prevent progression of emphysema

During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema -- well before symptoms occur -- may someday also be offered.

12 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

Novartis QAB149 receives FDA Pulmonary-Allergy Advisory Committee approval for COPD

An advisory committee recommended today that the Food and Drug Administration (FDA) approve QAB149 (indacaterol) 75 mcg in the US as a once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

9 Mar 2011

Emphysema News and Research

Latest Emphysema News and Research

Consumer groups, market experts support repeal of Medicare bidding program

WHO warns of tobacco dangers on World No Tobacco Day

Pulmonx announces new clinical data of Zephyr endobronchial valve in emphysema

Lung protein appears to play a key role in smoking-related emphysema

COPD Foundation to host biannual conference in the U.S. for the first time

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

Rotech Healthcare first quarter adjusted EBITDA increases 13% to $28.3 million

Workload, time constraints hold nurses to lead global fight against non-communicable diseases

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

Novartis NVA23 Phase III trial in COPD achieves primary end point

Scientist discovers new molecular mechanism underlying asthma, COPD

Merz launches 'Make Your Mark' campaign to raise awareness on cervical dystonia

Researchers develop non-steroid based strategy for patients with COPD

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

Rotech closes private offering of $290M in Senior Notes due 2018

EMP levels may help clinicians diagnose early emphysema

Test that measures destruction of lung air sacs, could help prevent progression of emphysema

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Novartis QAB149 receives FDA Pulmonary-Allergy Advisory Committee approval for COPD

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Emphysema News and Research

Latest Emphysema News and Research

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Newsletters you may be interested in